Catheter Precision (NYSEAMERICAN:VTAK – Get Free Report) is expected to be announcing its results before the market opens on Monday, May 11th. Analysts expect the company to announce earnings of ($20.90) per share and revenue of $1.60 million for the quarter.
Catheter Precision Price Performance
NYSEAMERICAN VTAK traded up $0.01 during trading hours on Monday, reaching $0.96. 54,260 shares of the company’s stock were exchanged, compared to its average volume of 861,758. The stock has a market cap of $2.59 million, a PE ratio of -0.05 and a beta of -1.04. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.46. The firm has a fifty day moving average of $1.21 and a 200-day moving average of $1.79. Catheter Precision has a one year low of $0.79 and a one year high of $15.68.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Catheter Precision stock. Millennium Management LLC acquired a new stake in Catheter Precision, Inc. (NYSEAMERICAN:VTAK – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 34,721 shares of the company’s stock, valued at approximately $64,000. Millennium Management LLC owned about 2.08% of Catheter Precision as of its most recent filing with the SEC. 20.34% of the stock is owned by hedge funds and other institutional investors.
Catheter Precision Company Profile
Catheter Precision, Inc (NYSE American: VTAK) is a medical device company specializing in the design, development and manufacture of catheter-based products for interventional cardiology and peripheral vascular procedures. The company’s core business centers on balloon catheter platforms, offering both standard and specialty catheter configurations that address applications ranging from percutaneous transluminal angioplasty (PTA) to percutaneous transluminal coronary angioplasty (PTCA). Catheter Precision’s product portfolio is engineered to meet diverse clinical needs, including high-pressure dilation, scored and cutting balloon therapies, and drug-coated balloon delivery.
All of Catheter Precision’s products are developed in its ISO 13485-certified, FDA-registered manufacturing facility in Bloomington, Minnesota.
Further Reading
Receive News & Ratings for Catheter Precision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catheter Precision and related companies with MarketBeat.com's FREE daily email newsletter.
